Media Rooms

Selected videos depicting Agilent instruments, software, services, and solutions providing trusted answers to our customers’ most challenging questions. Whether working with customers to keep food supplies safe, improve the quality of air, water and soil, or fight cancer with more precise diagnoses and targeted treatments, Agilent has a commitment to delivering insight and innovation toward improving the quality of life.

Cell and gene therapies have potential applications in many disease areas, including cancers, autoimmune, neurological, and rare diseases.

Agilent announced major new products at ASMS this year. Solutions that address challenges faced by our customers, providing greater efficiency and higher throughput, addressing increasing regulations, and the increasing data being generated.

PFAS continues to draw global attention to its impact on, and the important issues surrounding, one of our most critical natural resources, water. Agilent plays an important part in helping deliver solutions to address these issues.

Microplastic are found almost everywhere in the environment. Global concerns are emergent due to the unknown implications for human health and diverse ecosystems.

Wherever cancer research is in the pipeline, from the early discovery of cellular pathology to clinical trials to characterizing biologics in production or developing new diagnostic tools, Agilent is there. Focused on helping ensure success with solutions that will enable advances in cancer research, diagnostics, and therapeutic development.

We strive to consistently improve our sustainability in our operations, and also through our innovative products and technologies that address complex issues in a sustainable way.

Food authenticity is a growing issue and researchers investigating the validity of product labeling or supply chain integrity know that determining the origin or composition of foods can be an enormous challenge.

Industry initiatives to drive the inclusion of women in STEM careers are key. It is our responsibility to #embraceequality and embed it into our corporate culture to ensure long-term change, so that everyone has equal opportunities throughout their STEM careers.

Therapeutic oligonucleotides have emerged as an area of particular interest and promise in biopharmaceutical research because of their potential to treat a wide range of diseases.

Agilent COVID-19 media coverage and stories. Supporting our customers is a key priority for Agilent. Our global teams are hard at work to avoid disruptions from the COVID-19 virus, while at the same time acting responsibly to do what we can to prevent further spread.